Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Nov. 30, 2023
Nov. 30, 2022
CURRENT ASSETS    
Cash and cash equivalents $ 20,498 $ 20,068
Accounts receivable, net 2,945 5,915
Inventory, net 13,890 15,462
Prepaid expenses and other current assets 868 1,200
Total current assets 38,201 42,645
Deposits for equipment 1,163 2,269
Right-of-use-asset, net 1,805 2,424
Property and equipment, net 3,803 3,309
Intangible assets, net 3,583 3,872
Goodwill 2,258 2,258
Investment in joint venture 0 0
Loan to joint venture 1,473 0
Other assets 28 272
TOTAL ASSETS 52,314 57,049
CURRENT LIABILITIES    
Accounts payable and accrued liabilities 6,158 7,708
Operating lease liabilities, current 644 757
Deferred revenue 1,844 458
Total current liabilities 8,646 8,923
LONG TERM LIABILITIES    
Deferred revenue, non-current 91 340
Operating lease liabilities, non-current 1,258 1,792
Total Liabilities 9,995 11,055
COMMITMENTS AND CONTINGENCIES (NOTE 19)
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.001 par value, 5,000,000 shares authorized, no shares issued 0 0
Common stock, $0.001 par value, 50,000,000 shares authorized. 24,168,014 shares issued and 22,002,027 outstanding as of November 30, 2023 and, 24,018,612 shares issued and 21,852,625 outstanding as of November 30, 2022 24 23
Additional paid-in capital 130,426 125,474
Treasury stock (2,165,987 shares purchased as of November 30, 2023 and 2022) (17,500) (17,500)
Accumulated deficit (69,575) (61,383)
Accumulated other comprehensive loss (1,056) (620)
Total Stockholders’ Equity 42,319 45,994
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 52,314 $ 57,049